Cost of rifampicin-miconazole‒impregnated catheters


Intravenous literature: Lorente, L., Lecuona, M., Ramos, M.J., Jimanez, A., Mora, M.L. and Sierra, A. (2011) Lower associated costs using rifampicin-miconazole impregnated catheters compared with standard catheters. American Journal of Infection Control. Jul 6. [Epub ahead of print].


Previous cost-effectiveness analyses found that antibiotic-impregnated catheters decrease the incidence of catheter-related bloodstream infection (CRBSI) as well as the costs related to central venous catheter (CVC) use, including increased hospital length of stay. The effect varied greatly among the studies, however. In this retrospective cohort study, compared with standard catheters, the use of rifampicin-miconazole-impregnated catheters was associated with lower CRBSI incidence and immediate CVC-related costs (taking into account only the costs of CVC, diagnosis, and treatment of CRBSI) (P < .001). Our data indicate that the use of rifampicin-miconazole-impregnated catheters can save associated costs.

Main page


Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.